$NRGV

Top insider buys and sells disclosed for Thursday

Energy Vault (NRGV) director bought 27,472 shares at $3.88 each. Keurig Dr Pepper (KDP) director acquired 7,862 shares at $31.83. Welltower (WELL) director purchased 10,000 shares at $239.47-$242.06. American Assets (AAT) chairman bought 79,729 shares at $22.74-$22.89. Lumentum (LITE) exec sold 38,604 shares at $842.22-$860.05. Tempus AI (TEM) CEO sold 238,052 shares at $64.03-$70.58. CoreWeave (CRWV) CEO sold 307,692 shares at $88.31-$89.93. Illumina (ILMN) director sold 375,541 shares at $224.

Original reporting
Published Aug 28, 2026, 1:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 1:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$NRGV
Bullish
medium confidence
Mentioned
$NRGV · $KDP · $WELL · $AAT · $LITE · $TEM
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$NRGVBullishLow
01

Why it matters

Aggregated insider activity provides a snapshot of executive sentiment, with mixed signals across sectors.

02

Market read

Insider trades can influence short‑term price dynamics; the mix of large buys and sells offers traders nuanced signals.

03

What to watch

Option exercises and trust structures can mask true intent; some buys may be tax‑driven rather than confidence signals.

Relevance 6/10Novelty 7/10Timing: Thursday Aug 27, 2026

Background

The article aggregates recent Form 4 filings, highlighting notable insider purchases and sales for Thursday, Aug 27 2026.

Company-level read

Ticker impact

$NRGVBullishMedium confidence
Context

Director Dylan Hixon purchased 27,472 shares at $3.878 each, indicating confidence despite overvaluation.

Expected impact

Modest upside if market perceives confidence.

Evidence & confidence

Buy size relative to float is modest but signals insider belief.

$KDPBullishMedium confidence
Context

Director Aaron Alt bought 7,862 shares at $31.83, suggesting belief in undervaluation.

Expected impact

Slight upward pressure.

Evidence & confidence

Purchase size is small relative to market cap.

$WELLBullishMedium confidence
Context

Director Andrew Gundlach bought 10,000 shares for $2.41 M, reinforcing confidence near 52‑week high.

Expected impact

Potential short‑term rally.

Evidence & confidence

Significant dollar amount and proximity to high.

$AATBullishMedium confidence
Context

Executive Chairman Ernest Rady bought 79,729 shares for $1.82 M, indicating confidence in undervalued stock.

Expected impact

Modest upside.

Evidence & confidence

Large purchase by a 10% owner is noteworthy.

$LITEBearishMedium confidence
Context

Executive VP Vincent Retort sold 38,604 shares for $32.96 M under a 10b5‑1 plan.

Expected impact

Potential short‑term dip.

Evidence & confidence

Sale size is material; market may view as lack of confidence.

$TEMBearishMedium confidence
Context

CEO Eric Lefkofsky sold 238,052 shares for $16.29 M via 10b5‑1 plan.

Expected impact

Possible downside pressure.

Evidence & confidence

CEO sell size is large relative to market.

$CRWVBearishMedium confidence
Context

CEO Michael Intrator sold 307,692 shares for $27.3 M under a 10b5‑1 plan.

Expected impact

Downward pressure.

Evidence & confidence

CEO sale amount is material.

$ILMNBearishMedium confidence
Context

Director Keith Meister sold 375,541 shares for $85.2 M over three days.

Expected impact

Potential price decline.

Evidence & confidence

Large dollar value and multiple-day execution.

Market effects

Insider activity across consumer staples, tech, and industrials may signal sector‑wide confidence trends.

U.S. market sentiment may be modestly affected as multiple large‑cap names report insider moves.

Limited; primarily U.S. equity market focus.

Counterpoint

Large insider sells may be routine 10b5‑1 plans, not necessarily bearish.

Key entities

  • Dylan Hixon

    Director of Energy Vault Holdings who bought shares.

  • Aaron Alt

    Director of Keurig Dr Pepper who bought shares.

  • Vincent Retort

    Lumentum executive who sold shares under a 10b5‑1 plan.

Related articles

$KDPHighAI 9/10

JDE Peet’s shareholders to transfer to KDP before deadline

Keurig Dr Pepper (KDP) has set a 16 October 2026 deadline for JDE Peet’s shareholders to transfer shares. The court ordered a EUR 31.85 per-share price, with statutory interest from 1 April 2026. Non-transferred shares will face a statutory squeeze-out. KDP will pay EUR 31.85 plus interest by 19 October 2026. JDE Peet’s reported EUR 9.9 billion in 2025 sales.

$CRWVMed

CoreWeave’s $2.6 Billion AI Loan Has a Hidden Risk: Uptime Failures Could Force Early Debt Paydowns

CoreWeave Inc. (CRWV) has a $2.6B AI infrastructure loan with a risk of early repayment if customer contract breaches occur. Lenders focus on service-level agreements (SLAs) to avoid downtime threats. Poor performance can lead to contract terminations, triggering early debt repayment. The loan, priced at SOFR + 5.5%, has a five-year term but is backed by shorter customer contracts.

$CRWVMed

CoreWeave to Build First India AI Data Centers

CoreWeave is partnering with AdaniConneX to build AI data centers in India, investing billions over the project's lifespan. The first centers are expected to open in mid-2028, with an initial capacity of 240 megawatts, expandable to 480 megawatts. CoreWeave plans to use Nvidia's Vera Rubin chips and has secured about 4.2 gigawatts of contracted power globally. India's data center capacity is projected to grow significantly by 2030, with AI-specific capacity expected to increase nearly 24-fold.

$TEMMed

Tempus AI Doubles Down On Moderna and Merck Cancer Vaccine Infrastructure - Tempus AI (NASDAQ:TEM)

Tempus Inc. (TEM) expanded its collaboration with Moderna (MRNA) and Merck (MRK) to support the development of a cancer vaccine. Tempus will manage sample collection and provide NGS services. The company also partnered with Bristol Myers Squibb (BMY) to improve clinical trial design. Additionally, Tempus acquired Personalis (PSNL) for $1.5 billion to enhance cancer monitoring. TEM shares were down 1.94% to $70.58 at the time of publication.

$CRWVMed

CoreWeave Enters India With Multi-Billion Dollar Navi Mumbai AI Data Center Deal

CoreWeave (CRWV) will build its first Indian data centers, partnering with AdaniConneX for 240 MW capacity in Navi Mumbai, expandable to 480 MW. The project, costing billions, will use Nvidia (NVDA) systems and open in mid-2028. CoreWeave's stock slipped 2% premarket, though up 15% YTD. The deal highlights India's growing AI infrastructure demand, with data center capacity expected to reach 12 GW by 2030, per Wood Mackenzie.